The liquid inside every Wegovy pen should be clear and colorless regardless of the label color
Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alstrm Syndrome (AS) Patients With Moderate to Severe Obesity
Supporting Compliance and Regulatory Requirements Healthcare providers must comply with various regulatory requirements, including accurate coding and billing practices
Taking too little dose or too much medication could have serious risks and side effects
If a person does not have insurance, they may be eligible for Novo Nordisks Patient Assistance Program
By imitating the GLP-1 hormone in the gastrointestinal tract, Wegovy enhances insulin production, decreases blood sugar levels, promotes fullness, and suppresses appetite